Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | MGLL | Q99685 | 2/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.33 |
| ▸ | DRD2 | P14416 | 4/20 | 0.33 |
| ▸ | DRD4 | P21917 | 4/20 | 0.33 |
| ▸ | DRD3 | P35462 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.31 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11835650 | 0.86 | CHRM2 (0.34) | FAAHMGLLCHRM2CHRM4CHRM5 | |
| SCHEMBL10931036 | 0.84 | MGLL (0.54) | FAAHMGLLCYP19A1 | |
| SCHEMBL31252627 | 0.84 | MGLL (0.54) | FAAHMGLLCYP19A1 | |
| SCHEMBL1825898 | 0.84 | FAAH (0.50) | FAAHMGLLCYP19A1CHRM2CHRM4 | |
| SCHEMBL11836587 | 0.82 | FAAH (0.42) | FAAHMGLLCHRM2CHRM4CHRM5 | |
| SCHEMBL11591030 | 0.82 | — | — | |
| SCHEMBL11837219 | 0.82 | MEN1 (0.38) | FAAHMGLLCHRM2CHRM4CHRM5 | |
| SCHEMBL11850667 | 0.80 | MGLL (0.41) | FAAHMGLLCHRM2CHRM4CHRM5 | |
| SCHEMBL11848036 | 0.80 | MGLL (0.41) | FAAHMGLLCHRM2CHRM4CHRM5 | |
| SCHEMBL11837926 | 0.80 | MGLL (0.41) | FAAHMGLLCHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240352056-A1 | Improved methods for production of cyclic guanosine-monophosphate analogues | MIRECA MEDICINES GMBH (DE) | 2024-10-24 | — | — | US | disclosed |
| CN-117999269-A | Improved process for producing cyclic guanosine monophosphate analogues | 米雷卡医药有限公司 | 2024-05-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240352056-A1 | Improved methods for production of cyclic guanosine-monophosphate analogues | GMPS, CGAS, AMPD3 | FAAH 3927/4885MGLL 1216/4885CYP19A1 2843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.